glp-1 drugs in development Timeline of discovery and clinical development. (a) Key events Upcoming wave of hormone-based therapies

However, most formularies cover both Wegovy and Zepbound, so rebates are currently not driving competition, but rather stifling innovative management strategies

[DOI] [PubMed] [Google Scholar] 69.Park J., Ntelis S., Yunasan E., Downton K.D., Yip T.C.F., Munir K.M., Haq N

These findings are interesting, but they are not proof that GLP-1s prevent dementia

Retrieved from: Karagiannis et al., 2023

BCBC drug tiers may include: Tier 1: typically includes preferred generic drugs Tier 2: typically includes non-preferred generic drugs Tier 3: typically includes preferred brand-name drugs Tier 4: typically includes non-preferred brand-name drugs Tier 5: typically includes specialty drugs Tier 6: typically includes non-preferred specialty drugs Its also possible that your BCBS plan may include drug tiers such as: Tier 1: generic drugs and lower-cost preferred brand-name drugs Tier 2: non-preferred generic drugs or preferred brand-name drugs Tier 3: non-preferred brand-name drugs or drugs that have a lower-cost equivalent on a lower drug tier Tier 4: specialty drugs Ozempic is frequently placed in Tier 3 on the BlueMedicare PPO Enhanced plan provided by BlueCross BlueShield of North Carolina and is placed as a Tier 2 Preferred Brand drug on various HMO and PPO plans provided by Blue Shield of California

A helpful step forward would be to either de-list device patents in the Orange Book or require listing (thereby providing generic firms with transparency), but end the practice of awarding 30-month stays when such patents are litigated